Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

The combination treatment showed a higher response rate but no significant survival benefits.

Ketoconazole increases finasteride's effectiveness and lifespan in the body.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

The new finasteride delivery system using chitosan-based nanoniosomes shows promise for prostate cancer prevention.

Mice lacking fibromodulin have disrupted healing patterns, leading to abnormal skin repair and scarring.

Researchers found new potential but less potent rat enzyme inhibitors using a 3D model.

Indinavir, especially with vitamin A, may cause bone changes, but switching to nelfinavir can reduce these effects.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Certain natural compounds can block an enzyme linked to prostate enlargement and hair loss, showing potential for new treatments.

Finasteride and levofloxacin effectively reduce chronic bacterial prostatitis severity.

Fat tissue transplant may be an effective new treatment for severe, treatment-resistant hair loss from folliculitis decalvans.

FLCN helps control iron levels in cells.

MK-5108 is safe and shows potential against tumors, especially alone.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

PDRN from salmon may slow skin aging by improving skin quality and reducing inflammation.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

A new microneedle system effectively delivers a vasodilator to hair follicles, promoting hair growth better than current treatments.

Finasteride's solubility improves with native y-CDs, enhancing hair loss treatment and reducing side effects.

Recombinant Filaggrin-2 microneedles effectively promote hair growth and repair in hair loss.

The finasteride capsule is stable and effective for up to two years.

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

Frontal Fibrosing Alopecia involves disrupted cholesterol pathways, fibrosis, and increased mast cells.

Sorafenib can cause a temporary skin condition that goes away after stopping the drug.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.